Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CAMK2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
QDPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RIPK4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TAGLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R26-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TESPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF280B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUNDC3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT140 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP5S - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP4A11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FECH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFB2M - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on